TM plans to shift GR Corolla output to the United Kingdom to ease North America's delays, investing $56 million in Derbyshire to boost supply amid high demand.

TU's C$70 billion investment across Canada is built on a rich legacy of national support, with more than C$276 billion already invested since 2000.

From a technical perspective, Alpha and Omega Semiconductor (AOSL) is looking like an interesting pick, as it just reached a key level of support. AOSL recently overtook the 50-day moving average, and this suggests a short-term bullish trend.

SkyWater Technology, Inc. (SKYT) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SKYT broke through the 200-day moving average, which suggests a long-term bullish trend.

Although the revenue and EPS for Macy's (M) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Although the revenue and EPS for Capri Holdings (CPRI) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Although the revenue and EPS for Abercrombie (ANF) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Although the revenue and EPS for Dick's (DKS) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Report Illustrates How Tech-Savvy Organizations Are Gaining a Competitive Edge in the Age of AI CHARLESTON, S.C. , May 28, 2025 /PRNewswire/ -- The Blackbaud Institute, a research lab at Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today released a new report, The Status of Fundraising in the AI Era.

It is rare to find 9%+ yielding dividend growth stocks that would qualify as blue chips. However, today, Mr. Market is offering several of them. We share two that are attractive buys on the dip.

Kokai platform transition is complete, delivering significant cost and performance improvements for clients, and accelerating customer adoption beyond expectations. AI-driven enhancements, OpenPath, and retail media initiatives are fueling broad-based growth, with CTV as the largest and fastest-growing channel. The Trade Desk is gaining share as walled gardens face regulatory headwinds, and its independent, objective model is increasingly valued by advertisers and retailers.

OSUR remains deeply undervalued, trading below liquidation value, with a robust, cash-rich, debt-free balance sheet providing downside protection. Key value drivers include a 20% share buyback, potential building sale, and new product launches both in-house and via partnerships. Operational improvements—cost reductions, automation, and product diversification—should support gross margins and future growth.

ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC.

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.

CRM's $8 billion Informatica buyout move sharpens AI focus, supporting a hold rating amid soft revenue growth and underperforming stock.

SAN DIEGO , May 28, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of The Bancorp, Inc. (NASDAQ: TBBK). Investors who purchased shares of The Bancorp, Inc. (NASDAQ: TBBK) prior to February 2024 and continue to hold any of those NASDAQ: TBBK shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Meta Platforms, Inc. ("Meta Platforms, Inc.") (NASDAQ:META) concerning possible violations of federal securities laws. The Wall Street Journal published an article on May 15, 2025, entitled "Meta Is Delaying the Rollout of Its Flagship AI Model.